DK1874766T3 - Krystallinsk form af en quinolinon-carboxamid-forbindelse - Google Patents

Krystallinsk form af en quinolinon-carboxamid-forbindelse

Info

Publication number
DK1874766T3
DK1874766T3 DK06740692.6T DK06740692T DK1874766T3 DK 1874766 T3 DK1874766 T3 DK 1874766T3 DK 06740692 T DK06740692 T DK 06740692T DK 1874766 T3 DK1874766 T3 DK 1874766T3
Authority
DK
Denmark
Prior art keywords
quinolinone
crystalline form
carboxamide compound
carboxamide
compound
Prior art date
Application number
DK06740692.6T
Other languages
English (en)
Inventor
Paul R Fatheree
Adam Goldblum
Robert Chao
Daniel Genov
S Derek Turner
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DK1874766T3 publication Critical patent/DK1874766T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06740692.6T 2005-04-06 2006-04-05 Krystallinsk form af en quinolinon-carboxamid-forbindelse DK1874766T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66878005P 2005-04-06 2005-04-06
PCT/US2006/012978 WO2006108127A2 (en) 2005-04-06 2006-04-05 Crystalline form of a quinolinone-carboxamide compound

Publications (1)

Publication Number Publication Date
DK1874766T3 true DK1874766T3 (da) 2010-12-06

Family

ID=37074104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06740692.6T DK1874766T3 (da) 2005-04-06 2006-04-05 Krystallinsk form af en quinolinon-carboxamid-forbindelse

Country Status (30)

Country Link
US (4) US7728004B2 (da)
EP (1) EP1874766B1 (da)
JP (2) JP5230407B2 (da)
KR (1) KR101322873B1 (da)
CN (1) CN101151264B (da)
AR (2) AR053208A1 (da)
AT (1) ATE479682T1 (da)
AU (1) AU2006232129B2 (da)
BR (1) BRPI0610657A2 (da)
CA (1) CA2603654C (da)
CY (1) CY1111275T1 (da)
DE (1) DE602006016586D1 (da)
DK (1) DK1874766T3 (da)
EA (1) EA012115B1 (da)
ES (1) ES2350495T3 (da)
HK (1) HK1110866A1 (da)
HR (1) HRP20100629T1 (da)
IL (1) IL186023A (da)
MA (1) MA29403B1 (da)
MX (1) MX2007012438A (da)
MY (1) MY151075A (da)
NO (1) NO339699B1 (da)
NZ (1) NZ561900A (da)
PE (1) PE20061310A1 (da)
PL (1) PL1874766T3 (da)
PT (1) PT1874766E (da)
SI (1) SI1874766T1 (da)
TW (1) TWI377206B (da)
WO (1) WO2006108127A2 (da)
ZA (1) ZA200708071B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063671B2 (en) * 2002-06-21 2006-06-20 Boston Scientific Scimed, Inc. Electronically activated capture device
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
JP5042028B2 (ja) 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
JP5086091B2 (ja) * 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
EP2404919B1 (en) 2005-11-08 2013-08-21 Vertex Pharmaceuticals Incorporated Heterocyclic compound useful as a modulator of ATP-binding cassette transporters.
WO2008143916A2 (en) * 2007-05-17 2008-11-27 Theravance, Inc. Prokinetic agent for bowel preparation
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
PL2225230T3 (pl) 2007-12-07 2017-08-31 Vertex Pharmaceuticals Incorporated Stałe postacie kwasu 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-ilo)cyklopropanokarboksyamido)-3-metylopirydyn-2-ylo)benzoesowego
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AU2010236734B2 (en) * 2009-04-13 2015-06-11 Theravance Biopharma R&D Ip, Llc 5-HT4 receptor agonist compounds for treatment of cognitive disorders
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
WO2011095450A1 (en) 2010-02-02 2011-08-11 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
NZ602838A (en) 2010-04-07 2015-06-26 Vertex Pharma Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
MX2016006118A (es) 2013-11-12 2016-07-21 Vertex Pharma Proceso para preparar composiciones farmaceuticas para el tratamiento de enfermedades mediadas por regulador de la conductancia transmembrana de la fibrosis quistica (cftr).
CA3069989A1 (en) 2017-07-31 2019-02-07 Theravance Biopharma R&D Ip, Llc Methods of treating symptoms of gastroparesis using velusetrag
WO2024061960A1 (en) 2022-09-20 2024-03-28 Alfasigma S.P.A. Velusetrag for use in the treatment of chronic intestinal pseudo-obstruction (cipo)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3122671B2 (ja) 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
EP0564650B1 (en) * 1990-12-28 1995-09-20 Kyowa Hakko Kogyo Co., Ltd. Quinoline derivative
EP0670319A4 (en) 1992-11-20 1996-01-17 Thaisho Pharmaceutical Co Ltd HETEROCYCLIC COMPOUNDS.
JP3829879B2 (ja) 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
US7105195B2 (en) * 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
US7964727B2 (en) 2003-11-24 2011-06-21 Pfizer Inc. Quinolonecarboxylic acid compounds having 5-HT4 receptor agonistic activity
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
JP5086091B2 (ja) 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
JP5042028B2 (ja) 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
TW200640921A (en) 2005-02-17 2006-12-01 Theravance Inc Crystalline form of an indazole-carboxamide compound
WO2006094063A1 (en) 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound

Also Published As

Publication number Publication date
MY151075A (en) 2014-03-31
MA29403B1 (fr) 2008-04-01
JP2012153725A (ja) 2012-08-16
HRP20100629T1 (hr) 2010-12-31
US9126994B2 (en) 2015-09-08
CA2603654C (en) 2014-05-27
ATE479682T1 (de) 2010-09-15
NZ561900A (en) 2010-12-24
TWI377206B (en) 2012-11-21
AR110019A2 (es) 2019-02-13
WO2006108127A3 (en) 2007-01-04
EA012115B1 (ru) 2009-08-28
CN101151264A (zh) 2008-03-26
KR20070116988A (ko) 2007-12-11
TW200643020A (en) 2006-12-16
EA200702161A1 (ru) 2008-04-28
JP5230407B2 (ja) 2013-07-10
US20100197728A1 (en) 2010-08-05
DE602006016586D1 (de) 2010-10-14
AU2006232129A1 (en) 2006-10-12
CA2603654A1 (en) 2006-10-12
JP2008535848A (ja) 2008-09-04
IL186023A (en) 2011-09-27
CN101151264B (zh) 2011-07-06
EP1874766A2 (en) 2008-01-09
HK1110866A1 (en) 2008-07-25
KR101322873B1 (ko) 2013-10-30
US8658671B2 (en) 2014-02-25
US9402840B2 (en) 2016-08-02
US20060229332A1 (en) 2006-10-12
SI1874766T1 (sl) 2010-12-31
ZA200708071B (en) 2008-10-29
NO20075574L (no) 2007-11-02
WO2006108127A2 (en) 2006-10-12
US7728004B2 (en) 2010-06-01
MX2007012438A (es) 2007-12-05
BRPI0610657A2 (pt) 2010-07-13
AU2006232129B2 (en) 2012-07-12
NO339699B1 (no) 2017-01-23
US20160095849A1 (en) 2016-04-07
EP1874766B1 (en) 2010-09-01
CY1111275T1 (el) 2015-08-05
US20140256769A1 (en) 2014-09-11
ES2350495T3 (es) 2011-01-24
AR053208A1 (es) 2007-04-25
PT1874766E (pt) 2010-11-30
PL1874766T3 (pl) 2011-02-28
PE20061310A1 (es) 2007-01-23
IL186023A0 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
DK1874766T3 (da) Krystallinsk form af en quinolinon-carboxamid-forbindelse
DK1778672T3 (da) Krystallinsk form af en biphenylforbindelse
DK1856050T3 (da) Krystallinske former af en biphenylforbindelse
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
DK1937071T3 (da) Krystallinske modifikationer af pyraclostrobin
DK1924531T3 (da) Fjernelse af ammonium/ammoniak fra en strøm
DK2371818T3 (da) Hydroxybenzoatsalte af metanikotinforbindelser
DK3061467T3 (da) Sårforbinding med en bakterieadsorberende sammensætning
DK1919907T5 (da) Heterocyklisk forbindelse
DK1778618T3 (da) Syntese af triethylentetraminer
DK1877568T3 (da) Hydrolysering af arabinoxylan
DK1963302T3 (da) Polymorfer af en C-MET/HGFR-inhibitor
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1636190T3 (da) Stabilt krystal af 4-oxoquinolinforbindelse
DK2331538T3 (da) Krystallinske former af en 2-thiazolyl-4-quinolinyl-oxy-derivat, en potent HCV-inhibitor
ATE552254T1 (de) Trisubstituierte aminverbindung
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DK2083629T3 (da) Krystallinsk modifikation af fipronil
DK2149545T3 (da) Fremgangsmåde til fremstilling af en benzaldehydforbindelse
DK2117297T3 (da) Krystallinske komplekser af landbrugsmæssigt aktive organiske forbindelser
BRPI0814801A2 (pt) composto de piridazina cristalina
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
ITMI20050680A1 (it) Nuovi composti anti-infiammatori
DK1877403T3 (da) Mono-lysinsalte af azolforbindelser
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser